CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million
Calgary, AB – December 21, 2022 – CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today it received its cultivation license from Health Canada. The license, LIC-3JCQW6DIU0 is a major step towards production. A standard cultivation license is necessary for larger companies that want to build and […]
CannaPharmaRx Secures New Strains for Declaration to be Incorporated Into Product Portfolio
Calgary, AB – December 19, 2022 – CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today it has secured new genetic strains of cannabis for its declaration. This declaration gets submitted to Health Canada and will allow the new strains to be sold to other licensed producers.The company […]
